Editas Medicine (EDIT) stays a Hold as EDIT-401 nears trials; preclinical 90%+ LDL-C reduction for HeFH, but dilution and competition loom—read more macroanalysis here.
California just launched one of the most substantial EV incentive programs aimed specifically at ride-share drivers. Starting this month, eligible Uber, Lyft, and HopSkipDrive drivers can claim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results